Service Tax Additional
select a format
Recent Viewed Reports
Why Ken Reasearch?
While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"
We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"
The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"
Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"
We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"
Ocular Therapeutix, Inc. (Ocular) formerly I-Therapeutix, Inc., is a biopharmaceutical company that develops therapies for diseases using hydrogel platform technology. The company's products include DEXTENZA, sustained release travoprost and posterior segment injections. Its hydrogel technology uses polyethylene glycol to create ophthalmic sustained drug delivery systems. Ocular's hydrogel provides containment, localization and protection from inflammatory response, and a material for sustained delivery of drugs to the eye. The company also provides ReSure Sealant, a ocular sealant proven in clinical trial to be safe in sealing clear corneal incisions following cataract surgery. Its products are used for the treatment of glaucoma and ocular hypertension, post-operative inflammation, allergic conjunctivitis, dry eye and retinal diseases. Ocular is headquartered in Bedford, Massachusetts, the US.
Ocular Therapeutix, Inc. Key Recent Developments
Aug 09, 2016: Ocular Therapeutix Reports Second Quarter 2016 Financial Results and Provides Corporate Update
Aug 05, 2016: Ocular Therapeutix Announces Presentation at the Ophthalmology Innovation Summit at the American Society of Retina Specialists
May 10, 2016: Ocular Therapeutix Reports First Quarter 2016 Financial Results and Provides Corporate Update
Mar 10, 2016: Ocular Therapeutix Reports Fourth Quarter and Full Year 2015 Financial Results
Jan 11, 2016: Ocular Therapeutix Strengthens Executive Management Team with the Appointment of Highly Regarded Ophthalmologist Jonathan H. Talamo, M.D., as Chief Medical Officer
This comprehensive SWOT profile of Ocular Therapeutix, Inc. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Ocular Therapeutix, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
Business description-A detailed description of the company's operations and business divisions.
Corporate strategy-Analyst's summarization of the company's business strategy.
SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history-Progression of key events associated with the company.
Major products and services-A list of major products, services and brands of the company.
Key competitors-A list of key competitors to the company.
Key employees-A list of the key executives of the company.
Executive biographies-A brief summary of the executives' employment history.
Key operational heads-A list of personnel heading key departments/functions.
Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities-A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1-About the Company
Ocular Therapeutix, Inc.-Key Information
Ocular Therapeutix, Inc.-Overview
Ocular Therapeutix, Inc.-Key Employees
Ocular Therapeutix, Inc.-Key Employee Biographies
Ocular Therapeutix, Inc.-Key Operational Heads
Ocular Therapeutix, Inc.-Major Products and Services
Ocular Therapeutix, Inc.-History
Ocular Therapeutix, Inc.-Company Statement
Ocular Therapeutix, Inc.-Locations And Subsidiaries
Ocular Therapeutix, Inc.-Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2-Company Analysis
Ocular Therapeutix, Inc.-Business Description
Ocular Therapeutix, Inc.-Corporate Strategy
Ocular Therapeutix, Inc.-SWOT Analysis
Ocular Therapeutix, Inc.-Strengths
Ocular Therapeutix, Inc.-Weaknesses
Ocular Therapeutix, Inc.-Opportunities
Ocular Therapeutix, Inc.-Threats
Ocular Therapeutix, Inc.-Key Competitors
Section 3-Company Financial Performance Charts
Ocular Therapeutix, Inc.-Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Note*: Some sections may be missing if data is unavailable for the company
List of Figures
Ocular Therapeutix, Inc., Performance Chart
Ocular Therapeutix, Inc., Ratio Charts
List of Tables
Ocular Therapeutix, Inc., Key Information
Ocular Therapeutix, Inc., Key Ratios
Ocular Therapeutix, Inc., Share Data
Ocular Therapeutix, Inc., Major Products and Services
Ocular Therapeutix, Inc., History
Ocular Therapeutix, Inc., Key Employees
Ocular Therapeutix, Inc., Key Employee Biographies
Ocular Therapeutix, Inc., Key Operational Heads
Ocular Therapeutix, Inc., Other Locations
Ocular Therapeutix, Inc., Subsidiaries
Ocular Therapeutix, Inc., Key Manufacturing facilities
Ocular Therapeutix, Inc., Key Competitors
Ocular Therapeutix, Inc., SWOT Analysis
Ocular Therapeutix, Inc., Ratios based on current share price
Ocular Therapeutix, Inc., Annual Ratios
Ocular Therapeutix, Inc., Interim Ratios
Capital Market Ratios
Single User License:
Corporate User License:
Ocular Therapeutix, Inc., SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts